|
Volumn 340, Issue 25, 1999, Pages 1990-1991
|
Glucocorticoid therapy for chronic obstructive pulmonary disease
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BUDESONIDE;
GLUCOCORTICOID;
ASTHMA;
CHRONIC OBSTRUCTIVE LUNG DISEASE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
COST BENEFIT ANALYSIS;
DRUG MECHANISM;
DRUG MEGADOSE;
EDITORIAL;
HUMAN;
HUMAN CELL;
HUMAN TISSUE;
LONG TERM CARE;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
RISK BENEFIT ANALYSIS;
STEROID THERAPY;
UNITED STATES;
ADMINISTRATION, INHALATION;
ASTHMA;
BRONCHODILATOR AGENTS;
BUDESONIDE;
EOSINOPHILS;
GLUCOCORTICOIDS;
HUMANS;
INFLAMMATION;
LUNG DISEASES, OBSTRUCTIVE;
SPUTUM;
|
EID: 0033600281
PISSN: 00284793
EISSN: None
Source Type: Journal
DOI: 10.1056/NEJM199906243402509 Document Type: Editorial |
Times cited : (26)
|
References (17)
|